Hypha Labs, Inc.
FUNI
$0.03
$0.00-9.96%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -29.46% | 67.15% | 121.22% | 289.26% | 1,116.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.46% | 67.15% | 121.22% | 289.26% | 1,116.28% |
| Operating Income | 29.46% | -67.15% | -121.22% | -289.26% | -1,116.28% |
| Income Before Tax | 10.61% | -128.68% | -188.67% | -578.47% | -337.65% |
| Income Tax Expenses | -- | -- | -145.38% | -170.84% | -- |
| Earnings from Continuing Operations | 11.11% | -126.31% | -180.57% | -508.12% | -340.08% |
| Earnings from Discontinued Operations | -- | -- | -100.00% | -100.00% | -76.07% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.31% | -294.88% | -5,053.08% | -434.85% | -456.46% |
| EBIT | 29.46% | -67.15% | -121.22% | -289.26% | -1,116.28% |
| EBITDA | 13.13% | -162.92% | -358.96% | -8,701.74% | -6,283.38% |
| EPS Basic | 13.37% | -280.65% | -3,485.71% | -342.59% | -352.70% |
| Normalized Basic EPS | 41.95% | -23.73% | -45.63% | -109.09% | -314.29% |
| EPS Diluted | 3.62% | -198.96% | -966.67% | -421.30% | -398.65% |
| Normalized Diluted EPS | 41.95% | -23.73% | -45.63% | -109.09% | -314.29% |
| Average Basic Shares Outstanding | 28.19% | 33.37% | 36.68% | 37.57% | 30.07% |
| Average Diluted Shares Outstanding | 28.19% | 33.37% | 36.68% | 37.57% | 30.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |